Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biotene Oralbalance is a specialized moisturizing gel developed for the management of xerostomia (dry mouth) symptoms. It functions primarily as a saliva substitute and oral lubricant, designed to provide long-lasting relief from the discomfort of oral dryness. The formulation utilizes a combination of humectants and mucoadhesive polymers, such as glycerin and xylitol, which work to create a protective, moisture-retaining film over the oral mucosa. This film mimics the physical properties of natural saliva, reducing friction and soothing irritated tissues. While historical versions of the product contained an enzyme system (including lactoperoxidase, lysozyme, and glucose oxidase) to provide antimicrobial support, the current GlaxoSmithKline (GSK) formulations focus on optimized physical lubrication and moisture retention to improve patient comfort and oral health in those with diminished salivary flow.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biotene Oralbalance (GSK).